/
Login
Analysis Scores
Damodaran ?
54/100
Dalio Risk ?
86/100
Piotroski ?
4/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
$214.9
Pahalı
Active Metric?
4/4
Confidence?
75%
Valuation
Potential?
+2.9%
ROIC ?
28.2%
DCF Value ?
300.80
Debt Cycle?
Early Expansion
Data
Data ?
3594
2012-05-18 → 2026-09-03
Risk Analysis (VaR)
Yüksek
252 days
Annual Volatility ?
%39.0
VaR 95% ?
%4.10
daily max loss
VaR 99% ?
%5.77
daily max loss
CVaR 95% ?
%5.87
expected loss (tail)
Max Drawdown ?
%32.6
18.09.2025 → 27.03.2026
Skewness ?
-0.07
Parametrik%4.10
Historik%3.37
Cornish-Fisher%3.95
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Downtrend
Price (592.85), TRAMA-99 line's %8.8 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 592.85
TRAMA: 650.0396
Difference: %-8.8
Profitability
Net Profit Margin
%38.0
Net profit margin %38.0 — very strong. Compared to previous quarter +32.7 point increase.
ROE – Özkaynak Getirisi (TTM)
%12.4
ROE %12.4 — moderate return on equity.
EBITDA Margin
%52.1
EBITDA margin %52.1 — operationally very efficient.
Gross Profit Margin
%81.8
Gross profit per revenue %81.8. Strong pricing power.
Free Cash Flow Margin (TTM)
%22.9
TTM Free Cash Flow is %22.9'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio
24.8x
Sector: 32.7x
F/K 24.8x — sector medianna (32.7x) near reasonable levels.
P/B Ratio
6.90x
Sector: 4.59x
PD/DD 6.90x — sector median's %50 above. Expensive book value.
EV/EBITDA
14.6x
Sector: 21.8x
EV/EBITDA 14.6x — sector median's (21.8x) %33 below. EBITDA’ya göre undervalued.
Indebtedness
Current Ratio
2.60x
Current ratio 2.60x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA
0.8x
Net Borç/EBITDA 0.8x — very low debt burden. Company can repay debt quickly.
Debt / Equity
0.39x
Low leverage — majority of assets financed by equity.
Interest Coverage
151.9x
Interest coverage 151.9x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY)
%+23.8
Revenue YoY %23.8 grew — healthy growth rate.
Net Profit Growth (YoY)
%+9.3
Net profit YoY %9.3 increased — positive but moderate growth.
Score Explanations
Lothien Robustness
63/100
Good robustness (63/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+2.9%
Plus %2.9 expected value (610.18) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %75.
Components: PE target: 792.50 | P/B target: 425.78 | EV/EBITDA target: 884.43 | DCF target: 300.80
Damodaran Valuation
54/100
Moderate Damodaran score (54/100). ROIC (%28.2) – WACC (%10.4) farkı +17.8 baz puan. Value creation capacity limited.
Moderate
Dalio Risk Analysis
86/100
Low debt risk (86/100). Interest coverage ratio 151.9x — strong. Borç/EBITDA 0.8x — in healthy range.
Leverage: 82/100 | Debt Service: 100/100 | Quality: 97/100
ROIC – Sermaye Getirisi
%28.2
ROIC (%28.2) cost of capital 17.8 puan aşıyor → company creates value.
WACC: %10.4
DCF Discounted Cash Flow
300.80
DCF (300.80) current price %49.3 below — cash flows do not support current price.
Current price: 592.98
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
$214.9
Güncel fiyat Graham valuenin %63.8 üzerinde ($214.9) — Expensive by Graham.
Expensive
⚖️ Sector Comparison
P/E Ratio
24.8x
vs 32.7x
Sector mediannın %24 below — cheap
P/B Ratio
6.90x
vs 4.59x
Compared to sector %50 more expensive (by book value)
EV/EBITDA
14.6x
vs 21.8x
Compared to sector %33 lower EV/EBITDA
ROIC vs WACC
%28.2
vs %10.4 WACC
ROIC 17.8 baz puan exceeds cost of capital
Net Profit Margin (TTM)
%30.1
vs %52.6 EBITDA margin
TTM net profit margin %30.1
Charts
Indicators
BB deviation
?
RSI thresholds
?
▲ içeriden alım ·
▼ içeriden satım ·
★ katalizör (haber-sezgisel) ·
■ 13D aktivist ·
■ 13G pasif
— SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
İçeriden Alım-Satım Akışı
Kim aldı, kim sattı, ne kadar
META — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.